NLRP3 and obesity due to melanocortin 4 receptor deficiency: Preclinical studies have shown that baicalin also exhibits antidepressant effects via GSK3β/NF-κB/NLRP3 signaling and HPA axis normalization, also mitigating obesity and insulin resistance in diabetic patients [89].